Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis.
暂无分享,去创建一个
R. Lewis | S. Daiger | S. Bowne | L. Sullivan | J. Heckenlively | L. Hedstrom | D. Birch | Sir Mortimer | D. Hughbanks-Wheaton | Anisa I. Gire | C. J. Spellicy | Jingya Zhu | S. J. Bowne | Catherine J. Spellicy
[1] G. Fish,et al. Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene. , 2005, American journal of ophthalmology.
[2] L. Hedstrom,et al. Autosomal dominant retinitis pigmentosa mutations in inosine 5'-monophosphate dehydrogenase type I disrupt nucleic acid binding. , 2005, The Biochemical journal.
[3] T. L. McGee,et al. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn. , 2005, Investigative ophthalmology & visual science.
[4] G. Fishman,et al. A novel IMPDH1 mutation (Arg231Pro) in a family with a severe form of autosomal dominant retinitis pigmentosa. , 2004, Ophthalmology.
[5] L. Hedstrom,et al. Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo. , 2004, The Biochemical journal.
[6] L. Hedstrom,et al. Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction. , 2004, Biochemistry.
[7] I. Alberts,et al. On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa. , 2004, Human molecular genetics.
[8] A. Kennan,et al. Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) mice. , 2002, Human molecular genetics.
[9] Seth Blackshaw,et al. Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. , 2002, Human molecular genetics.
[10] Marianne Haim,et al. Epidemiology of retinitis pigmentosa in Denmark. , 2002, Acta ophthalmologica Scandinavica. Supplement.
[11] L. Hedstrom,et al. IMP dehydrogenase: mechanism of action and inhibition. , 1999, Current medicinal chemistry.
[12] C. Freund,et al. A range of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene. , 1998, American journal of human genetics.
[13] B. Mitchell,et al. Regulation of the Human Inosine Monophosphate Dehydrogenase Type I Gene , 1997, The Journal of Biological Chemistry.
[14] E. Berson,et al. Retinitis pigmentosa: unfolding its mystery. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] V. Sheffield,et al. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. , 1993, Archives of ophthalmology.
[16] Alan Bird,et al. Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy , 1993, Nature Genetics.
[17] S. Daiger,et al. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies , 2001, Human mutation.
[18] Y. Natsumeda,et al. Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205). , 1994, Life sciences.